Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolpidem EEG for Prognosis in Disorders of Consciousness
NCT02948660Phase 2Completed
- Sponsor
- Xijing Hospital
- Start
- Dec 2017
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Phase 2, open-label trial of zolpidem sublingual tablet in disorders of consciousness (DoC) (2 arms), sponsored by Xijing Hospital. Primary endpoint: Coma Recovery Scale-Revised at 6 months. Started Dec 2017; status: completed.
02
Drugs
zolpidem sublingual tablet
03
Conditions
disorders of consciousness (DoC)
Beyond the preview
Go deeper on NCT02948660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02948660.